A Study to Learn About the Study Medicine Sisunatovir in Adults With Respiratory Syncytial Virus (RSV) Infection

NCT06079320 · clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
TERMINATED
Status
16
Enrollment
INDUSTRY
Sponsor class

Stopped Study discontinued due to business reasons. There were no safety concerns in the decision to stop study and no changes to sponsor's assessment of the risk-benefit profile for participants who received sisunatovir in the study.

Conditions

Interventions

Sponsor

Pfizer